Luxbright (LXB) H2 2025 earnings summary

Executive summary

• Achieved 40% sales growth year-over-year, driven by increased demand for proprietary X-ray tubes and sources.

• Transitioned from a development company to an industrial manufacturing partner with proven delivery capability.

• Strengthened commercial position through international collaborations, notably with Fisica Inc. in the US.

• Leadership transition announced: Patrik Hallberg to succeed Mats Alm as CEO in May 2026.

Financial highlights

• Net sales for Jan–Dec 2025: 11,415 KSEK (up from 9,022 KSEK in 2024).

• Operating result for Jan–Dec 2025: -19,237 KSEK (2024: -18,059 KSEK).

• Net result per share for Jan–Dec 2025: -0.16 SEK (2024: -0.17 SEK).

• Cash flow from operations: -19,873 KSEK; total cash flow: -7,060 KSEK.

• Equity at year-end: 26,895 KSEK; cash and bank: 5,295 KSEK.

Outlook and guidance

• No quantified forecast for 2026; company is well positioned for continued commercialization.

• Additional financing will be required in the first half of 2026; various capital raising options are under discussion.